John Michael Ketcham

8 Patents

• US124212282025

  Naphthyridine Derivatives as PRC2 Inhibitors

  MIRATI THERAPEUTICS, Inc.

  0 cites
• US123714352025

  Substituted Imidazo[1,2-c]pyrimidines as PRC2 Inhibitors

  MIRATI THERAPEUTICS, Inc.

  0 cites
• US123049152025

  SOS1 Inhibitors

  MIRATI THERAPEUTICS, Inc.

  0 cites
• US122800552025

  Combination Therapies

  MIRATI THERAPEUTICS, Inc.

  0 cites
• US122524932025

  Imidazo[1,2-c]pyrimidine Derivatives as PRC2 Inhibitors for Treating Cancer

  MIRATI THERAPEUTICS, Inc.

  0 cites
• US120981392024

  Chemokine Receptor Modulators and Uses Thereof

  RAPT Therapeutics, Inc.

  0 cites
• US119649892024

  Kras G12D Inhibitors

  Array Biopharma Inc.

  0 cites
• US117024182023

  SOS1 Inhibitors

  MIRATI THERAPEUTICS, Inc.

  0 cites